Construction and validation of a predictive model for the risk of myelosuppression after first-line chemotherapy in patients with advanced colorectal cancer
Objective To investigate the risk factors influencing the incidence of chemotherapy-induced myelosuppression (CIM) following first-line chemotherapy in patients with moderately advanced colorectal cancer (CRC), and to develop and validate a nomogram to assess the risk of CIM in the patients.Methods...
Saved in:
Main Authors: | WANG Xuexing, ZHANG Rong, CHU Jie, LIU Zhijin |
---|---|
Format: | Article |
Language: | zho |
Published: |
Editorial Office of New Medicine
2025-01-01
|
Series: | Yixue xinzhi zazhi |
Subjects: | |
Online Access: | https://yxxz.whuznhmedj.com/futureApi/storage/attach/2501/BQZWUdZRuM8ugw6wghfJMtarD7iuWktNmhL1hHk4.pdf |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy of first-line radiofrequency ablation combined with systemic chemotherapy plus targeted therapy for initially unresectable colorectal liver metastases
by: Yaqing Kong, et al.
Published: (2025-12-01) -
Effect of trilaciclib administered before chemotherapy in patients with extensive-stage small-cell lung cancer: A pooled analysis of four randomized studies
by: Ying Liu, et al.
Published: (2024-01-01) -
Enhancing chemotherapy response prediction via matched colorectal tumor-organoid gene expression analysis and network-based biomarker selection
by: Wei Zhang, et al.
Published: (2025-02-01) -
The Financial Toxicity Experience of Patients with Colorectal Cancer During Chemotherapy: A Qualitative Study
by: Yanli Yao, et al.
Published: (2024-12-01) -
The Impact of Nutritional Status and Tumor-Infiltrating Lymphocytes (CD4+ and CD8+) on Chemotherapy Response in Colorectal Cancer Patients
by: Lukman K, et al.
Published: (2025-01-01)